Browse

Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study

DC Field Value Language
dc.contributor.authorChang, Sung Hae-
dc.contributor.authorPark, Jin Kyun-
dc.contributor.authorLee, Yun Jong-
dc.contributor.authorYang, Ji Ae-
dc.contributor.authorLee, Eun Yang-
dc.contributor.authorSong, Yeong Wook-
dc.contributor.authorLee, Eun Bong-
dc.date.accessioned2017-03-21T04:24:47Z-
dc.date.available2017-03-21T13:56:57Z-
dc.date.issued2014-08-28-
dc.identifier.citationArthritis Research & Therapy, 6(4):428ko_KR
dc.identifier.urihttps://hdl.handle.net/10371/109901-
dc.description.abstractIntroduction
Rheumatic diseases (RDs) are associated with different cancers; however, it is unclear whether particular cancers are more prevalent in certain RDs. In the present study, we examined the relative incidence of several cancers in a single homogeneous cohort of patients with different RDs.

Methods
Patients (N = 3,586) diagnosed with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), dermatomyositis (DM) or polymyositis were included. Cancer diagnosis was based on histopathology. The 2008 Korean National Cancer Registry served as the reference for calculating standardized incidence ratios (SIRs).

Results
During the follow-up period of 31,064 person-years, 187 patients developed cancer. RA and SLE patients showed an increased risk of non-Hodgkins lymphoma (SIR for RA patients = 3.387, 95% confidence interval (CI) = 1.462 to 6.673; SIR for SLE patients = 7.408, 95% CI = 2.405 to 17.287). SLE patients also had a higher risk of cervical cancer (SIR = 4.282, 95% CI = 1.722 to 8.824). SSc patients showed a higher risk of lung cancer (SIR = 4.917, 95% CI = 1.977 to 10.131). Endometrial cancer was increased only in patients with DM (SIR = 30.529, 95% CI = 3.697 to 110.283). RA patients had a lower risk for gastric cancer (SIR = 0.663, 95% CI = 0.327 to 0.998). The mean time between the RD and cancer diagnoses ranged from 0.1 to 16.6 years, with the shortest time observed in patients with DM (2.0 ± 2.1 years).

Conclusions
Different RDs are associated with particular cancers. Thus, cancer surveillance tailored to specific RDs might be beneficial.
ko_KR
dc.language.isoenko_KR
dc.publisherBioMed Centralko_KR
dc.titleComparison of cancer incidence among patients with rheumatic disease: a retrospective cohort studyko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor장성해-
dc.contributor.AlternativeAuthor박진균-
dc.contributor.AlternativeAuthor이윤정-
dc.contributor.AlternativeAuthor양지애-
dc.contributor.AlternativeAuthor이은양-
dc.contributor.AlternativeAuthor송영욱-
dc.contributor.AlternativeAuthor이은봉-
dc.identifier.doi10.1186/s13075-014-0428-x-
dc.language.rfc3066en-
dc.rights.holderChang et al.; licensee BioMed Central Ltd.-
dc.date.updated2017-01-06T10:47:20Z-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
Files in This Item:
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse